Christopher J. Kirk - Jun 23, 2022 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
President and CSO, Director
Signature
/s/ Marc Belsky, Attorney-in-fact
Stock symbol
KZR
Transactions as of
Jun 23, 2022
Transactions value $
$29,754
Form type
4
Date filed
6/27/2022, 06:30 PM
Previous filing
Jan 7, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Options Exercise $29.8K +33.1K +9.49% $0.90 381K Jun 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Options Exercise $0 -33.1K -21.14% $0.00 123K Jun 23, 2022 Common Stock 33.1K $0.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total reflects 1,953, 981, 986, 951 and 944 shares of common stock acquired on May 15, 2020, November 15, 2020, May 15, 2021, November 15, 2021 and May 15, 2022, respectively, through the Company's 2018 Employee Stock Purchase Plan.
F2 Fully vested and exercisable.